Teva Pharmaceutical Industries Ltd (TEVA) — Cash Flow Reinvestment Rate
Teva Pharmaceutical Industries Ltd (TEVA) has a Cash Flow Reinvestment Rate of 0.54x as of March 2026, reinvesting ILA167.56 Million (capex ILA167.56 Million ) from operating cash flow of ILA313.17 Million. Explore TEVA capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Teva Pharmaceutical Industries Ltd Cash Flow Reinvestment Rate (1991–2025)
Historical reinvestment intensity for Teva Pharmaceutical Industries Ltd across 34 annual periods. Also explore total assets of Teva Pharmaceutical Industries Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Teva Pharmaceutical Industries Ltd (1991–2025)
Year-by-year capital reinvestment analysis for Teva Pharmaceutical Industries Ltd. For live market cap and broader valuation context, see Teva Pharmaceutical Industries Ltd (TEVA) total market value.
| Year | Reinvestment Rate | Total Reinvested (ILA) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | ILA557.32 Million | ILA3.10 Billion | ILA542.32 Million | ▼ -57.6% |
| 2024 | 0.42x | ILA529.00 Million | ILA1.25 Billion | ILA498.00 Million | ▼ -57.4% |
| 2023 | 0.99x | ILA1.36 Billion | ILA1.37 Billion | ILA526.00 Million | ▲ +187.1% |
| 2022 | 0.35x | ILA551.00 Million | ILA1.59 Billion | ILA548.00 Million | ▼ -59.7% |
| 2021 | 0.86x | ILA687.00 Million | ILA798.00 Million | ILA562.00 Million | ▲ +68.6% |
| 2020 | 0.51x | ILA621.00 Million | ILA1.22 Billion | ILA578.00 Million | ▲ +119.8% |
| 2019 | 0.23x | ILA125.00 Million | ILA538.00 Million | ILA119.00 Million | ▼ -26.2% |
| 2018 | 0.31x | ILA770.00 Million | ILA2.45 Billion | ILA651.00 Million | ▲ +2.8% |
| 2017 | 0.31x | ILA1.07 Billion | ILA3.51 Billion | ILA874.00 Million | ▼ -95.6% |
| 2016 | 7.01x | ILA36.64 Billion | ILA5.22 Billion | ILA901.00 Million | ▲ +1300.5% |
| 2015 | 0.50x | ILA2.77 Billion | ILA5.54 Billion | ILA772.00 Million | ▲ +104.9% |
| 2014 | 0.24x | ILA1.25 Billion | ILA5.13 Billion | ILA929.00 Million | ▼ -33.6% |
| 2013 | 0.37x | ILA1.19 Billion | ILA3.24 Billion | ILA1.03 Billion | ▲ +52.4% |
| 2012 | 0.24x | ILA1.10 Billion | ILA4.57 Billion | ILA1.10 Billion | ▼ -5.2% |
| 2011 | 0.25x | ILA1.05 Billion | ILA4.13 Billion | ILA1.05 Billion | ▲ +48.4% |
| 2010 | 0.17x | ILA710.00 Million | ILA4.14 Billion | ILA710.00 Million | ▼ -19.5% |
| 2009 | 0.21x | ILA719.00 Million | ILA3.37 Billion | ILA719.00 Million | ▲ +1.1% |
| 2008 | 0.21x | ILA681.00 Million | ILA3.23 Billion | ILA681.00 Million | ▼ -29.5% |
| 2007 | 0.30x | ILA542.00 Million | ILA1.81 Billion | ILA542.00 Million | ▲ +57.8% |
| 2006 | 0.19x | ILA390.00 Million | ILA2.06 Billion | ILA390.00 Million | ▼ -16.3% |
| 2005 | 0.23x | ILA310.10 Million | ILA1.37 Billion | ILA310.10 Million | ▼ -9.1% |
| 2004 | 0.25x | ILA311.00 Million | ILA1.25 Billion | ILA311.00 Million | ▼ -24.8% |
| 2003 | 0.33x | ILA207.50 Million | ILA626.60 Million | ILA207.50 Million | ▼ -27.0% |
| 2002 | 0.45x | ILA160.40 Million | ILA353.70 Million | ILA160.40 Million | ▼ -7.6% |
| 2001 | 0.49x | ILA134.07 Million | ILA273.15 Million | ILA134.07 Million | ▼ -9.1% |
| 2000 | 0.54x | ILA89.42 Million | ILA165.63 Million | ILA89.42 Million | ▲ +23.6% |
| 1999 | 0.44x | ILA67.07 Million | ILA153.61 Million | ILA67.07 Million | ▼ -77.4% |
| 1998 | 1.93x | ILA135.60 Million | ILA70.20 Million | ILA135.60 Million | ▲ +489.8% |
| 1997 | 0.33x | ILA63.40 Million | ILA193.60 Million | ILA63.40 Million | ▼ -69.3% |
| 1995 | 1.07x | ILA112.60 Million | ILA105.40 Million | ILA112.60 Million | ▼ -48.7% |
| 1994 | 2.08x | ILA79.50 Million | ILA38.20 Million | ILA79.50 Million | ▲ +73.2% |
| 1993 | 1.20x | ILA45.30 Million | ILA37.70 Million | ILA45.30 Million | ▲ +24.1% |
| 1992 | 0.97x | ILA27.30 Million | ILA28.20 Million | ILA27.30 Million | ▼ -60.5% |
| 1991 | 2.45x | ILA22.30 Million | ILA9.10 Million | ILA22.30 Million | — |